US Stock MarketDetailed Quotes
IBRX ImmunityBio
- 7.910
- -0.150-1.86%
Trading May 10 15:18 ET
5.47BMarket Cap-7324P/E (TTM)
8.310High7.730Low3.02MVolume7.880Open8.060Pre Close24.19MTurnover1.88%Turnover RatioLossP/E (Static)691.57MShares10.53052wk High-7.90P/B1.27BFloat Cap1.25052wk Low--Dividend TTM160.49MShs Float45.420Historical High--Div YieldTTM7.20%Amplitude0.930Historical Low8.016Avg Price1Lot Size
ImmunityBio Stock Forum
Sign in to post a comment
$ImmunityBio(IBRX.US$ is the earning good or bad
2
$ImmunityBio(IBRX.US$ this stock can drop 10% in one day then jump 15%. Kinda a wild ride
1
$ImmunityBio(IBRX.US$ is tmr the earning announcement ?
2
ImmunityBio's strategic investments and partnerships are set to play a pivotal role in shaping the future of cancer treatment.
ImmunityBio, Inc. (NASDAQ: IBRX) has announced the successful completion and qualification of the drug substance for ANKTIVA® (nogapendekin alfa inbakicept-pmln), paving the way for the production of 170,000 doses. This achievement underscores ImmunityBio's commitment to addressin...
ImmunityBio, Inc. (NASDAQ: IBRX) has announced the successful completion and qualification of the drug substance for ANKTIVA® (nogapendekin alfa inbakicept-pmln), paving the way for the production of 170,000 doses. This achievement underscores ImmunityBio's commitment to addressin...
$ImmunityBio(IBRX.US$ are people shorting this stock rn?
1
$ImmunityBio(IBRX.US$ ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient For 170,000 Doses Of ANKTIVA
Benzinga· 2 mins ago
ANKTIVA Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product
ImmunityBio's 400,000 square foot GMP fill-finish facility in Dunkirk, New York on track to be completed in 12-18 months with capacity to produce a million vials annually
Coupled with a recent announcement of BCG availabilit...
Benzinga· 2 mins ago
ANKTIVA Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product
ImmunityBio's 400,000 square foot GMP fill-finish facility in Dunkirk, New York on track to be completed in 12-18 months with capacity to produce a million vials annually
Coupled with a recent announcement of BCG availabilit...
4
$ImmunityBio(IBRX.US$ anyone knoww what happened? :(
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
2deMoonmoon : bad
Invest Long ✓OP : bad outlook?